Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Lipid Res ; 61(3): 376-386, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31919051

RESUMO

Angiopoietin-like protein 3 (ANGPTL3) inhibits lipid clearance and is a promising target for managing cardiovascular disease. Here we investigated the effects of a high-sugar (high-fructose) diet on circulating ANGPTL3 concentrations in rhesus macaques. Plasma ANGPTL3 concentrations increased ∼30% to 40% after 1 and 3 months of a high-fructose diet (both P < 0.001 vs. baseline). During fructose-induced metabolic dysregulation, plasma ANGPTL3 concentrations were positively correlated with circulating indices of insulin resistance [assessed with fasting insulin and the homeostatic model assessment of insulin resistance (HOMA-IR)], hypertriglyceridemia, adiposity (assessed as leptin), and systemic inflammation [C-reactive peptide (CRP)] and negatively correlated with plasma levels of the insulin-sensitizing hormone adropin. Multiple regression analyses identified a strong association between circulating APOC3 and ANGPTL3 concentrations. Higher baseline plasma levels of both ANGPTL3 and APOC3 were associated with an increased risk for fructose-induced insulin resistance. Fish oil previously shown to prevent insulin resistance and hypertriglyceridemia in this model prevented increases of ANGPTL3 without affecting systemic inflammation (increased plasma CRP and interleukin-6 concentrations). ANGPTL3 RNAi lowered plasma concentrations of ANGPTL3, triglycerides (TGs), VLDL-C, APOC3, and APOE. These decreases were consistent with a reduced risk of atherosclerosis. In summary, dietary sugar-induced increases of circulating ANGPTL3 concentrations after metabolic dysregulation correlated positively with leptin levels, HOMA-IR, and dyslipidemia. Targeting ANGPTL3 expression with RNAi inhibited dyslipidemia by lowering plasma TGs, VLDL-C, APOC3, and APOE levels in rhesus macaques.


Assuntos
Proteínas Semelhantes a Angiopoietina/antagonistas & inibidores , Dislipidemias/tratamento farmacológico , Óleos de Peixe/farmacologia , Frutose/antagonistas & inibidores , Interferência de RNA , Proteínas Semelhantes a Angiopoietina/sangue , Proteínas Semelhantes a Angiopoietina/metabolismo , Animais , Suplementos Nutricionais , Dislipidemias/sangue , Dislipidemias/induzido quimicamente , Óleos de Peixe/administração & dosagem , Inflamação/metabolismo , Lipoproteínas/metabolismo , Macaca mulatta , Masculino
2.
Biomolecules ; 9(10)2019 10 11.
Artigo em Inglês | MEDLINE | ID: mdl-31614639

RESUMO

We investigated whether short term high fructose intake may induce early hepatic dysfunction in rats and to test whether allopurinol treatment may have beneficial effects. Twenty male Sprague-Dawley rats received 20% fructose in drinking water (10 treated with allopurinol and 10 received vehicle) and 10 control rats received tap water. After 14 days, the hepatic response to an acute fructose load was evaluated, and in fasted animals, respirometry studies in freshly isolated mitochondria were performed. In fasting rats, we did not find differences in systemic or hepatic uric acid and triglyceride concentrations among the groups, but mitochondrial respiratory control rate was significantly decreased by high fructose feeding and correlated with a reduced expression of Complex I, as well as decreased aconitase-2 activity. On the other hand, in fructose fed rats, an acute fructose load increased systemic and hepatic uric acid, triglycerides and oxidative stress. Fructose feeding was also associated with fructokinase and xanthine oxidase overexpression and increased liver de novo lipogenesis program (fatty acid synthase (FAS) and cell death-inducing DFFA-like effector C (CIDEC) overexpression, ATP citrate lyase (ACL) and acetyl coA carboxylase (ACC) overactivity and decreased AMP-activated protein kinase (AMPk) and endothelial nitric oxide synthase (eNOS) activation). Allopurinol treatment prevented hepatic and systemic alterations. These data suggest that early treatment with xanthine oxidase inhibitors might provide a therapeutic advantage by delaying or even halting the progression of non-alcoholic fatty liver disease (NAFLD).


Assuntos
Alopurinol/farmacologia , Frutose/antagonistas & inibidores , Lipogênese/efeitos dos fármacos , Hepatopatia Gordurosa não Alcoólica/tratamento farmacológico , Administração Oral , Alopurinol/administração & dosagem , Animais , Apoptose/efeitos dos fármacos , Inibidores Enzimáticos/administração & dosagem , Inibidores Enzimáticos/farmacologia , Frutose/administração & dosagem , Frutose/farmacologia , Masculino , Hepatopatia Gordurosa não Alcoólica/metabolismo , Hepatopatia Gordurosa não Alcoólica/patologia , Ratos , Ratos Sprague-Dawley
3.
Cell Biol Toxicol ; 35(5): 471-483, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31102011

RESUMO

Fructose is an important alternative carbon source for several tumors, and GLUT5 is the major fructose transporter which mediates most of fructose uptake in cells. So far, it is unclear whether GLUT5-mediated fructose utilization is important for clear cell renal cell carcinoma (ccRCC). Here, we demonstrated that GLUT5 was highly expressed in a panel of ccRCC cell lines. High GLUT5 expression exacerbated the neoplastic phenotypes of ccRCC cells, including cell proliferation and colony formation. On the other hand, deletion of the GLUT5-encoding gene SLC2A5 dramatically attenuated cellular malignancy via activating the apoptotic pathway. Moreover, administration of 2,5-anhydro-D-mannitol (2,5-AM), a competitive inhibitor of fructose uptake, could markedly suppress ccRCC cell growth. Together, we provide a new mechanistic insight for GLUT5-mediated fructose utilization in ccRCC cells and highlight the therapeutic potential for targeting this metabolic pathway against ccRCC.


Assuntos
Carcinoma de Células Renais/metabolismo , Frutose/metabolismo , Transportador de Glucose Tipo 5/metabolismo , Neoplasias Renais/metabolismo , Animais , Apoptose/efeitos dos fármacos , Apoptose/fisiologia , Transporte Biológico , Carcinoma de Células Renais/patologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/fisiologia , Feminino , Frutose/antagonistas & inibidores , Células HEK293 , Xenoenxertos , Humanos , Neoplasias Renais/patologia , Manitol/análogos & derivados , Manitol/farmacologia , Camundongos , Camundongos Endogâmicos BALB C , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ensaios Antitumorais Modelo de Xenoenxerto
4.
Free Radic Biol Med ; 112: 298-307, 2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-28754499

RESUMO

Type 2 diabetes are at a high risk of complications related to hypertension, and reports have indicated that insulin levels may be associated with blood pressure (BP). Fructose intake has recently been reported to promote insulin resistance and superoxide formation. The aim of this study is to investigate whether fructose intake can enhance superoxide generation and impair insulin signaling in the NTS and subsequently elevate BP in rats with fructose-induced hypertension. Treatment with fructose for 4 weeks increased the BP, serum fasting insulin, glucose, homeostatic model assessment-insulin resistance, and triglyceride levels and reduced the serum direct high-density lipoprotein level in the fructose group. The Tempol treatment recovered the fructose-induced decrease in nitric oxide production in the NTS. Immunoblotting and immunofluorescence analyses further showed that fructose increased the p38- and fructose-induced phosphorylation of insulin receptor substrate 1 (IRS1S307) and suppressed AktS473 and neuronal nitric oxide synthase phosphorylation. Similarly, fructose was able to impair insulin sensitivity and increase insulin levels in the NTS. Fructose intake also increased the production of superoxide in the NTS. The results of this study suggest that fructose might induce central insulin resistance and elevate BP by enhancing superoxide production and activating p38 phosphorylation in the NTS.


Assuntos
Diabetes Mellitus Experimental/metabolismo , Frutose/administração & dosagem , Hipertensão/metabolismo , Resistência à Insulina , Núcleo Solitário/efeitos dos fármacos , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo , Animais , Antioxidantes/farmacologia , Glicemia/metabolismo , Pressão Sanguínea/efeitos dos fármacos , Óxidos N-Cíclicos/farmacologia , Diabetes Mellitus Experimental/induzido quimicamente , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/patologia , Frutose/antagonistas & inibidores , Regulação da Expressão Gênica , Hipertensão/induzido quimicamente , Hipertensão/tratamento farmacológico , Hipertensão/patologia , Insulina/sangue , Proteínas Substratos do Receptor de Insulina/genética , Proteínas Substratos do Receptor de Insulina/metabolismo , Lipoproteínas HDL/metabolismo , Masculino , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase Tipo I/genética , Óxido Nítrico Sintase Tipo I/metabolismo , Fosforilação , Proteínas Proto-Oncogênicas c-akt/genética , Proteínas Proto-Oncogênicas c-akt/metabolismo , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY , Transdução de Sinais , Núcleo Solitário/metabolismo , Núcleo Solitário/patologia , Marcadores de Spin , Superóxidos/agonistas , Superóxidos/antagonistas & inibidores , Superóxidos/metabolismo , Triglicerídeos/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/genética
5.
Nicotine Tob Res ; 13(11): 1084-91, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21799193

RESUMO

INTRODUCTION: Tobacco smoking is a widespread phenomenon, and nicotine is the addictive component of tobacco. Nicotine acts through nicotinic cholinergic receptors and has been associated with different types of psychophysical disorders in human beings. The present study had explored the proconvulsive action of nicotine and its effect on the antiseizure efficacy of topiramate against kainic acid (KA)-induced seizures in mice. METHODS: The study had evaluated the dose-response curves for nicotine and KA and for KA in nicotine-pretreated mice and for topiramate against KA-induced seizures. Mecamylamine was used to antagonize the nicotinic receptor-mediated actions of nicotine. CD50 (convulsive dose in 50% of animals) for KA and nicotine and ED50 (effective dose in 50% of animals as anticonvulsant) for topiramate were determined. Brain lipid peroxidation studies were also undertaken in the treated mice. RESULTS: Nicotine significantly potentiated the convulsive action of KA acid and reduced the CD50 (95% confidence limits [CL]) value for KA from 2.6 mg/kg (2.3-3.1) to 1.4 mg/kg (0.9-2.1), intraperitoneally (i.p.). Topiramate pretreatment significantly inhibited KA-induced seizures and brain lipid peroxidation with ED50 (95% CL) value of 21.90 mg/kg (17.3-28.2), i.p. Nicotine pretreatment caused dose-dependent antagonism to the antiseizure and antilipid peroxidative actions of topiramate. Mecamylamine had antagonized the proconvulsant action of nicotine. CONCLUSION: The study highlights the fact that intake of nicotine, through agonism to nAChR, might predispose epileptic patients to lower seizure threshold and induce a state of refractoriness to the protective effects of the antiepileptic drugs, resulting in possible breakthrough seizure attacks.


Assuntos
Anticonvulsivantes/uso terapêutico , Agonistas de Aminoácidos Excitatórios/toxicidade , Frutose/análogos & derivados , Ácido Caínico/toxicidade , Nicotina/farmacologia , Convulsões/tratamento farmacológico , Animais , Anticonvulsivantes/antagonistas & inibidores , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Interações Medicamentosas , Frutose/antagonistas & inibidores , Frutose/uso terapêutico , Humanos , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Mecamilamina/farmacologia , Camundongos , Antagonistas Nicotínicos/farmacologia , Receptores Nicotínicos/efeitos dos fármacos , Convulsões/induzido quimicamente , Convulsões/prevenção & controle , Topiramato
6.
Indian J Exp Biol ; 48(8): 800-10, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21341538

RESUMO

To study the effect and mode of action of water extract (DVW) and polar fraction of ethanol extract (DVE-4) of D. viscosa in high-fructose diet induced insulin resistance in male Wistar rats. D. viscosa's effects were evaluated on a battery of targets involved in glucose homeostasis (in vitro studies). Rats were rendered insulin resistant by feeding 66% (w/w) fructose and 1.1% (v/w) coconut oil mixed with normal pellet diet (NPD) for six weeks. DVW and DVE4 at different doses were administered simultaneously. At the end of the study, blood glucose, oral glucose tolerance test, lipid profile and insulin were estimated and homeostatic model assessment (HOMA) levels were calculated. In addition, enzymatic and nonenzymatic liver antioxidant levels were also estimated. Quantification of biomarker quercetin was done using HPLC. Fructose diet with DVW, DVE-4 significantly reduced blood glucose, serum insulin, HOMA, lipid profiles and significantly improved glucose tolerance and HDL-c levels. In addition, these extract and fraction also decreased oxidative stress by improving endogenous antioxidants. In different bioassays, DVW and DVE-4 inhibited protein tyrosine phosphatase-1B with IC50 65.8 and 54.9 microg/ml respectively and showed partial inhibition of dipeptidyl peptidase-IV. Moreover, DVW and DVE-4, at 10 microg/ml showed 60 and 54.2% binding to peroxisome proliferator-activated receptor-gamma. Further, 2.1% (w/w) of quercetin was quantified in bioactive-DVE-4 using HPLC method. The results provide pharmacological evidence of D. viscosa in treatment of prediabetic conditions and these effects may be mediated by interacting with multiple targets operating in diabetes mellitus.


Assuntos
Diabetes Mellitus Experimental/prevenção & controle , Frutose/antagonistas & inibidores , Frutose/toxicidade , Resistência à Insulina , Componentes Aéreos da Planta/química , Extratos Vegetais/farmacologia , Sapindaceae/química , Animais , Antioxidantes/metabolismo , Glicemia/metabolismo , Dieta , Dipeptidil Peptidase 4/metabolismo , Modelos Animais de Doenças , Teste de Tolerância a Glucose , Hipoglicemiantes/farmacologia , Insulina/farmacologia , Masculino , Estresse Oxidativo , PPAR gama/metabolismo , Fitoterapia , Proteína Tirosina Fosfatase não Receptora Tipo 1/metabolismo , Quercetina/isolamento & purificação , Quercetina/farmacologia , Ratos , Ratos Wistar
7.
Endocrine ; 31(3): 294-9, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17906378

RESUMO

Exposure of normal rats to fructose-containing drinking water represents a current model of insulin resistance. The major aim of the present study was to assess the possible effect of diet supplementation with either olive oil or guar upon the metabolic consequences of exposure to exogenous fructose. For this purpose, the changes in body weight, plasma D-glucose and insulin concentrations, and D-glucose infusion rate during a hyperinsulinemic-euglycemic clamp were measured after 65 days exposure to exogenous fructose and either olive oil- or guar-enriched diet. The results were compared to those previously collected in control animals exposed for the same period to either tap water or the fructose-containing drinking water and a standard diet. Diet supplementation with olive oil or guar failed to affect the increase in the insulinogenic index and the decrease in insulin sensitivity and fasted/fed ratio for plasma insulin concentration caused by exogenous fructose. In the rats exposed to exogenous fructose, the olive oil-fed rats differed from other animals by the absence of a decrease in food intake and body weight gain, whilst the guar-fed rats differed from other animals in a lower plasma D-glucose concentration in fed state and an absence, at day 65, of a higher plasma D-glucose concentration than that at day 0 measured in after overnight fasting state. These findings argue in favour of guar, rather than olive oil, to oppose the effect of exogenous fructose on glucose homeostasis.


Assuntos
Cyamopsis , Frutose/antagonistas & inibidores , Resistência à Insulina , Óleos de Plantas/administração & dosagem , Animais , Glicemia/metabolismo , Peso Corporal , Cyamopsis/química , Dieta , Suplementos Nutricionais , Ingestão de Alimentos , Jejum , Frutose/efeitos adversos , Técnica Clamp de Glucose , Teste de Tolerância a Glucose , Insulina/sangue , Antagonistas da Insulina/administração & dosagem , Masculino , Azeite de Oliva , Fitoterapia , Preparações de Plantas/administração & dosagem , Ratos , Ratos Wistar
8.
J Insect Physiol ; 49(12): 1115-24, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14624883

RESUMO

Aphidius ervi Haliday (Hymenoptera, Braconidae) is an endophagous parasitoid of several aphid species of economic importance, widely used in biological control. The definition of a suitable artificial diet for in vitro mass production of this parasitoid is still an unresolved issue that, to be properly addressed, requires a deeper understanding both of its nutritional needs and of the functional properties of the larval epithelia involved in nutrient absorption. The experimental evidence presented in this paper unequivocally demonstrates that the uptake of sugars and amino acids takes place through the body surface of the larval stages of A. ervi. These nutrients are efficiently absorbed by the larval epidermis, but the transport rate progressively declines over time. The epidermis exhibits a cross-reactivity to antibodies raised against the mammalian facilitative glucose transporter GLUT2 and the sodium cotransporter SGLT1. The analysis of sugar transport sensitivity to specific inhibitors indicates the involvement of GLUT2-like transporters, while a role for SGLT1-like transporters is not supported. The peculiar pathways of nutrient absorption in A. ervi larvae further corroborate the general idea that the pre-imaginal stages of endophagous koinobiont Hymenoptera, like Metazoan parasites, show a high degree of physiological integration with their hosts.


Assuntos
Aminoácidos/metabolismo , Afídeos/metabolismo , Epiderme/metabolismo , Frutose/metabolismo , Glucose/metabolismo , Absorção , Animais , Afídeos/crescimento & desenvolvimento , Autorradiografia , Membrana Celular/metabolismo , Membrana Celular/ultraestrutura , Citocalasinas/farmacologia , Imunofluorescência , Frutose/antagonistas & inibidores , Glucose/análogos & derivados , Glucose/antagonistas & inibidores , Transportador de Glucose Tipo 2 , Hemócitos/metabolismo , Jejuno/metabolismo , Larva/metabolismo , Larva/ultraestrutura , Proteínas de Transporte de Monossacarídeos/análise , Proteínas de Transporte de Monossacarídeos/metabolismo , Floretina/farmacologia , Florizina/farmacologia , Ratos , Sódio/farmacologia , ATPase Trocadora de Sódio-Potássio/análise , ATPase Trocadora de Sódio-Potássio/metabolismo
9.
Pol J Pharmacol ; 55(5): 799-802, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14704477

RESUMO

Nicotine administered acutely at subconvulsive dose of 4 mg/kg, significantly decreased the protective activity of valproate, carbamazepine, diphenylhydantoin, phenobarbital, topiramate and lamotrigine against maximal electroshock-induced tonic convulsions in mice. The obtained data may suggest that interaction between nicotine and antiepileptic drugs should be carefully considered as a cause of the therapeutic failure in epileptic patients.


Assuntos
Anticonvulsivantes/antagonistas & inibidores , Frutose/análogos & derivados , Nicotina/administração & dosagem , Nicotina/efeitos adversos , Animais , Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/farmacocinética , Carbamazepina/administração & dosagem , Carbamazepina/antagonistas & inibidores , Carbamazepina/farmacocinética , Relação Dose-Resposta a Droga , Interações Medicamentosas , Eletrochoque , Frutose/administração & dosagem , Frutose/antagonistas & inibidores , Frutose/farmacocinética , Humanos , Injeções Intraperitoneais , Lamotrigina , Camundongos , Nicotina/farmacocinética , Fenobarbital/administração & dosagem , Fenobarbital/antagonistas & inibidores , Fenobarbital/farmacocinética , Fenitoína/administração & dosagem , Fenitoína/antagonistas & inibidores , Fenitoína/farmacocinética , Convulsões/induzido quimicamente , Convulsões/fisiopatologia , Convulsões/prevenção & controle , Topiramato , Triazinas/administração & dosagem , Triazinas/antagonistas & inibidores , Triazinas/farmacocinética , Ácido Valproico/administração & dosagem , Ácido Valproico/antagonistas & inibidores , Ácido Valproico/farmacocinética
10.
J Bacteriol ; 148(3): 912-8, 1981 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7309680

RESUMO

In stationary phase, 95% of the fructosyltransferase (FTase) activity of Streptococcus salivarius ATCC 25975 was found associated with the cells. Within the first 15 min after inoculation into fresh medium, the specific activity of cell-associated FTase decreased by 92% of its initial value. After this period of initial loss, the enzyme was synthesized during exponential growth until a maximum level equivalent to that present before inoculation was obtained. The inactivation of FTase was also demonstrated in a nongrowing system. Washed cell suspensions incubated at 37 degrees C in 200 mM potassium phosphate buffer (pH 6.5) containing 10 microM Cu2+ lost 80 to 95% of their FRase activity after 30 min. This loss could be prevented by the addition of histidine, cysteine, or Ca2+ to the suspension mixture. A factor(s) essential for the inactivation of cell-associated FTase could itself be preferentially inactivated by heating cells at 40 degrees C for periods of up to 3 h, or by storage of cells at 0 to 4 degrees C for several days in a low-ionic-strength, low-pH, potassium phosphate buffer. Treatment of cells with the N-acetylmuramidase enzyme M-1, in the presence of 0.5 M melezitose, resulted in the release of FTase from the cell. The released enzyme was recovered in the supernatant fraction after centrifugation at 160,000 x g for 90 min. Comparison of solubilized active and inactivated FTase preparations by polyacrylamide gel electrophoresis demonstrated that the inactivation of cell-associated FTase activity was associated with the loss of specific protein bands.


Assuntos
Hexosiltransferases/antagonistas & inibidores , Streptococcus/enzimologia , Proteínas de Bactérias/metabolismo , Cálcio/farmacologia , Meios de Cultura , Cisteína/farmacologia , Frutose/antagonistas & inibidores , Frutose/metabolismo , Hexosiltransferases/metabolismo , Concentração de Íons de Hidrogênio , Streptococcus/crescimento & desenvolvimento , Sacarose/antagonistas & inibidores , Sacarose/metabolismo , Temperatura
11.
Proc Natl Acad Sci U S A ; 78(11): 6667-9, 1981 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-6458816

RESUMO

Sucrose synthase (UDPglucose:D-fructose 2-alpha-D-glucosyltransferase, EC2.4.1.13), which catalyzes the synthesis and cleavage of sucrose, exhibits differences in some properties between the two reactions. When enzyme previously incubated with oxidized glutathione or oxidized thioredoxin was used, sucrose cleavage was inhibited whereas sucrose synthesis proceeded at a normal rate. Sucrose cleavage activity could be restored by incubation with dithiothreitol or reduced glutathione. The thioredoxin effect was influenced by the presence of cleavage reaction substrates--i.e., sucrose and UDP. Thioredoxin action was rather slow compared with the catalytic reaction. These findings may have important implications for understanding the metabolic role of sucrose synthase and oxidized thioredoxin. Theoretically, the fact that an enzyme catalyzing a reversible reaction is inhibited in one direction only suggests that a modification in the enzyme affinities for its substrates must have occurred.


Assuntos
Dissulfetos/farmacologia , Glucosiltransferases/antagonistas & inibidores , Ácido Ascórbico/farmacologia , Frutose/antagonistas & inibidores , Glutationa/farmacologia , Cinética , Oxirredução , Plantas/enzimologia , Tiorredoxinas/farmacologia , Triticum/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA